Literature DB >> 9753549

Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin.

A Krebs1, C Villa, P C Edwards, G F Schertler.   

Abstract

Dialysis of rhodopsin isolated from bovine rod outer segments resulted in the formation of a new two-dimensional crystal form suitable for electron crystallography. The crystals obtained were tubular or single layers and showed p22121 symmetry (a=60.6(+/-0.8) A, b=86.3(+/-1.6) A). For the first time the size and order of the crystals allowed us to take electron diffraction patterns showing spots to a resolution of about 3.5 A. Images were recorded at liquid nitrogen temperature using a high voltage field emission electron microscope. Out of a large number of images 20 crystalline areas were selected and processed with the MRC image processing software. A projection structure of bovine rhodopsin to 5 A resolution was calculated using amplitudes and phases extracted from these images. The achieved resolution exceeds the resolution of all previously obtained structures of frog, bovine and squid rhodopsin crystals. In this map small differences are observed compared to the previous maps. Helix 5 seems to be even more highly tilted and between the arc-shaped feature and helix 5 a peak is present suggesting that helix 3 is prolonging this feature towards helix 5. These observations are in agreement with the latest model for the three-dimensional arrangement of rhodopsin. The resolution achieved as well as the availability of electron diffraction data suggest that there is a good possibility to collect data from tilted crystals and calculate an improved three-dimensional structure of rhodopsin. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753549     DOI: 10.1006/jmbi.1998.2070

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Projection structure and oligomeric properties of a bacterial core protein translocase.

Authors:  I Collinson; C Breyton; F Duong; C Tziatzios; D Schubert; E Or; T Rapoport; W Kühlbrandt
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Oligomeric forms of G protein-coupled receptors (GPCRs).

Authors:  Krzysztof Palczewski
Journal:  Trends Biochem Sci       Date:  2010-06-09       Impact factor: 13.807

4.  Imaging whole Escherichia coli bacteria by using single-particle x-ray diffraction.

Authors:  Jianwei Miao; Keith O Hodgson; Tetsuya Ishikawa; Carolyn A Larabell; Mark A LeGros; Yoshinori Nishino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

Review 5.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 6.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

Review 7.  The year in G protein-coupled receptor research.

Authors:  Robert P Millar; Claire L Newton
Journal:  Mol Endocrinol       Date:  2009-12-17

8.  An olfactory receptor pseudogene whose function emerged in humans: a case study in the evolution of structure-function in GPCRs.

Authors:  Peter C Lai; Gautam Bahl; Maryse Gremigni; Valery Matarazzo; Olivier Clot-Faybesse; Catherine Ronin; Chiquito J Crasto
Journal:  J Struct Funct Genomics       Date:  2008-09-19

Review 9.  Structural insights into G-protein-coupled receptor activation.

Authors:  William I Weis; Brian K Kobilka
Journal:  Curr Opin Struct Biol       Date:  2008-11-17       Impact factor: 6.809

10.  Electron crystallography reveals the structure of metarhodopsin I.

Authors:  Jonathan J Ruprecht; Thorsten Mielke; Reiner Vogel; Claudio Villa; Gebhard F X Schertler
Journal:  EMBO J       Date:  2004-08-26       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.